跳至主要内容
临床试验/NCT04423068
NCT04423068已完成早期 1 期

Intervention to Facilitate Contraception Provision by Pediatric Hospitalists: A Feasibility Study

Children's Mercy Hospital Kansas City1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2020年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Feasibility of SexHealth II, an intervention to provide contraception counseling and initiation among hospitalized female adolescents

研究概览

简要总结

The overall goal of this study is to refine and pilot test the investigators novel intervention to offer contraception counseling and initiation for hospitalized female adolescents, focusing on long acting reversible contraception (LARC).

详细描述

There are two primary objectives in this study. The first objective is to refine the investigators previously developed general sexual risk reduction intervention (SexHealth II) to focus on patient-centered contraception counseling and initiation for hospitalized female adolescents. The second objective is to conduct an open trial to assess feasibility of the investigators SexHealth II intervention among hospitalized females aged 14-21 years (N=75). Among key stakeholders (i.e., adolescent participants, parents/guardians, hospitalists and nurses), the investigators will assess Bowen's feasibility constructs: acceptability, demand, implementation, practicality, integration, and limited-efficacy testing. The investigators hypothesize that the SexHealth II intervention will be deemed feasible by female adolescent participants (i.e., the median score across all feasibility items will be > 2.5.)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 21 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Adolescents who are biologically female and have reproductive potential (14-21 years old) admitted to the general pediatric hospitalist service will be eligible.
  • A convenience sample of parents/guardians of enrolled participants who are English speaking will be eligible for post-intervention feasibility survey. Parent consent or enrollment in the study is not required for female adolescent enrollment.
  • A convenience sample of hospitalists and nurses caring for enrolled participants and the health educator will be eligible for the post-intervention feasibility study.

排除标准

  • Subjects who are determined to be too ill, have severe psychiatric illness or cognitive impairment (based on hospitalist assessment), are seeking care related to sexual assault, or are not able to speak English fluently will not be eligible.
  • Parents/guardians, hospitalists, health educator and nurses who are not able to speak English fluently will not be eligible for post-intervention feasibility survey.
  • Adults unable to consent - Exclude
  • Individuals who are not yet adults (infants, children, teenagers) - Include
  • Pregnant women - Exclude
  • Prisoners - Exclude
  • Wards of the state - Include
  • Withdraw Criteria:
  • Subjects who are screened and report no sexual activity (past or anticipated "unlikely"/"very likely" within few weeks to months) will be withdrawn from the study.

研究组 & 干预措施

Overall Study

Experimental

干预措施: SexHealth II (Behavioral)

Overall Study

Experimental

干预措施: Contraceptive (Drug)

结局指标

主要结局

Feasibility of SexHealth II, an intervention to provide contraception counseling and initiation among hospitalized female adolescents

时间窗: 3 months

The investigators primary outcome is feasibility of the intervention among female adolescent participants, which the investigators will assess by administering a survey with 12 Likert-type items with responses ranging from 0 (strongly disagree) to 4 (strongly agree). The midpoint (neutral) point on the 0-4 scale is 2, and the investigators define "acceptable level of feasibility" as the median feasibility rating in the population exceeding 2.5, meaning at least half the ratings are positive. Thus, the investigators will test the hypothesis that the true median feasibility rating in the population of adolescents from which the sample is drawn is greater than 2.5. The investigators expect the true median is above 2.5. Assuming its value is conservatively 2.75, a sample size of 75 provides 90% power to reject H0 using a two-sided sign test for the population median.

次要结局

未报告次要终点

研究者

发起方
Children's Mercy Hospital Kansas City
申办方类型
Other
责任方
Principal Investigator
主要研究者

Abbey Masonbrink

Physician, Hospital Medicine

Children's Mercy Hospital Kansas City

研究点 (1)

Loading locations...

相似试验